LXEO - Lexeo Therapeutics, Inc.

QQQ $ 441.33 $ 0.87 (0.2 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 3.37 (0.65 %)

TLT $ 90.69 $ 0.50 (0.55 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 14.5

Open

$ 13.96

Bid

$ 14.40 x 100

Ask

$ 0.00 x 0

Day's Range

$ 13.96 - $ 16.68

52 Week Range

$ 9.00 - $ 22.33

Volume

56,954

Average Volume

Market Cap

383.88M

Beta (5Y Monthly)

$ 1.16

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-11-2024	12-31-2023	10-K
3	12-11-2023	09-30-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

matterport-sea-limited-ingevity-and-other-big-stocks-moving-higher-on-monday

Matterport, Sea Limited, Ingevity And Othe...
04/22/2024 14:10:39

Lexeo Therapeutics Announces In-License Ag...
04/22/2024 11:32:21

Lexeo Therapeutics shares are trading high...
04/16/2024 11:37:09

Lexeo Therapeutics Granted FDA Fast Track ...
04/16/2024 11:31:58

RBC Capital Maintains Outperform Rating fo...
03/12/2024 17:00:15

RBC Capital Maintains Outperform on Lexeo ...
03/12/2024 15:29:52

RBC Capital analyst Luca Issi maintains Lexeo Therapeutics (NASDAQ:LXEO) with a Outperform and raises the price target from ...

LEXO shares are trading higher after the c...
03/11/2024 11:59:37

Lexeo Therapeutics Q4 EPS $(0.86) Up From ...
03/11/2024 11:55:59

Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.86) per share. This is a 90.29 percent increase over losses o...

Lexeo Therapeutics Reveals Oversubscribed ...
03/11/2024 11:39:29

The company announced it has entered into a common stock purchase agreement with a select group of institutional and healthcare...

Box Reports Upbeat Earnings, Joins America...
03/06/2024 16:45:28

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

why-keycorp-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why KeyCorp Shares Are Trading Lower By Ov...
01/18/2024 18:08:48

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results...

fastenal-posts-upbeat-earnings-joins-novocure-taiwan-semiconductor-manufacturing-and-other-big-stocks-moving-higher-on-thursday

Fastenal Posts Upbeat Earnings, Joins Novo...
01/18/2024 15:10:06

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Fastenal Company (NASDAQ: ...

Marathon Digital, Canaan, CleanSpark And O...
12/26/2023 15:16:02

U.S. stocks traded higher, with the Dow Jones index gaining around 40 points on Tuesday. Here are some big stocks recording lo...

Lexeo Therapeutics Says FDA Granted Fast T...
12/18/2023 12:12:13

LX2020 is AAVrh10-based gene therapy candidate designed to intravenously deliver a functional PKP2 gene to cardiac muscle for t...

Lexeo Therapeutics Q3 EPS $(12.36) Down Fr...
12/11/2023 12:10:36

Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(12.36) per share. This is a 19.08 percent decrease over losses ...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
12/01/2023 21:31:06

Chardan Capital Initiates Coverage On Lexe...
11/28/2023 13:19:38

Chardan Capital analyst Geulah Livshits initiates coverage on Lexeo Therapeutics (NASDAQ:LXEO) with a Buy rating and announc...

Leerink Partners Initiates Coverage On Lex...
11/28/2023 13:11:50

Leerink Partners analyst Mani Foroohar initiates coverage on Lexeo Therapeutics (NASDAQ:LXEO) with a Outperform rating and a...

RBC Capital Initiates Coverage On Lexeo Th...
11/28/2023 11:44:16

RBC Capital analyst Luca Issi initiates coverage on Lexeo Therapeutics (NASDAQ:LXEO) with a Outperform rating and announces ...

Stifel Initiates Coverage On Lexeo Therape...
11/28/2023 11:42:29

Stifel analyst Paul Matteis initiates coverage on Lexeo Therapeutics (NASDAQ:LXEO) with a Buy rating and announces Price Tar...